Key Insights
The global Biobanking Industry is poised for significant expansion, projected to reach a market size of $52.72 million by 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 4.99%. This robust growth is fueled by a confluence of technological advancements and increasing investments in life sciences research. Key drivers include the burgeoning demand for regenerative medicine, the critical role of biobanking in drug discovery and development, and the growing imperative for advanced disease research, particularly in areas like oncology and genetic disorders. The market is experiencing a surge in demand for sophisticated cryogenic storage systems, including advanced refrigerators, ice machines, and freezers, alongside sophisticated alarm monitoring systems to ensure sample integrity. The increasing focus on personalized medicine further elevates the importance of meticulously collected and stored samples of human tissue, stem cells, cord blood, and DNA/RNA. Emerging trends highlight the integration of artificial intelligence and automation in biobanking processes, enhancing efficiency and data management. Furthermore, there's a growing emphasis on standardization and regulatory compliance, ensuring the reliability and usability of banked samples for global research initiatives.
Biobanking Industry Market Size (In Million)
Despite the promising outlook, the industry faces certain restraints that could temper its trajectory. These include the high initial investment required for establishing and maintaining state-of-the-art biobanking facilities, stringent regulatory frameworks that can be complex and time-consuming to navigate, and concerns surrounding data privacy and security of sensitive biological samples and associated patient information. However, the relentless pursuit of breakthroughs in healthcare, coupled with expanding collaborations between research institutions and private companies, is expected to offset these challenges. The market is witnessing active participation from leading companies such as Becton Dickinson and Company, Thermo Fisher Scientific Inc., and Merck KGaA, among others, who are continuously innovating to meet the evolving needs of the biobanking ecosystem. Geographic expansion is notable, with North America and Europe currently leading the market, while the Asia Pacific region is demonstrating substantial growth potential due to increasing R&D investments and a rising prevalence of chronic diseases.
Biobanking Industry Company Market Share
Biobanking Industry Market Analysis Report: Unlocking Precision Medicine & Research Advancements
This comprehensive report delves into the burgeoning biobanking industry, providing critical insights for stakeholders navigating this dynamic and rapidly evolving sector. With a projected market size of $11 million by 2025, the biobanking landscape is poised for significant expansion, driven by advancements in regenerative medicine, drug discovery, and disease research. This analysis covers the period from 2019–2033, with a detailed focus on the 2025–2033 forecast period, offering actionable intelligence for companies, researchers, and policymakers.
Biobanking Industry Market Dynamics & Concentration
The biobanking industry exhibits a moderate to high concentration, with key players such as Becton Dickinson and Company, Thermo Fisher Scientific Inc., and Avantor (VWR International LLC) holding substantial market share. Innovation drivers are primarily fueled by the increasing demand for personalized medicine and advancements in genomic sequencing technologies. Regulatory frameworks are becoming more stringent, with a strong emphasis on data privacy and sample integrity, creating both challenges and opportunities for compliance-focused solutions. Product substitutes are limited, with direct competition revolving around advanced storage technologies and integrated sample management software. End-user trends highlight a growing preference for centralized biobanking facilities and cloud-based data management solutions. Mergers and acquisitions (M&A) activity remains a significant factor, with approximately 10-15 M&A deals anticipated annually, consolidating market presence and fostering technological integration.
- Market Concentration: Moderate to High
- Innovation Drivers: Regenerative Medicine, Drug Discovery, Genomic Technologies
- Regulatory Landscape: Stringent Data Privacy and Sample Integrity focus
- Product Substitutes: Limited, competition focused on technology and software
- End-User Trends: Centralized biobanking, Cloud-based data management
- M&A Activity: Anticipated 10-15 deals annually
Biobanking Industry Industry Trends & Analysis
The biobanking industry is experiencing robust growth, projected to witness a Compound Annual Growth Rate (CAGR) of xx% during the forecast period. This expansion is underpinned by a confluence of factors, including the increasing prevalence of chronic diseases, a surge in R&D investments by pharmaceutical and biotechnology companies, and the growing recognition of the immense value of biological samples for disease research and the development of novel therapeutics. Technological disruptions are transforming the industry, with the adoption of automation in sample processing, advanced cryogenic storage systems capable of maintaining ultra-low temperatures, and sophisticated AI-powered analytics for data interpretation. Consumer preferences are shifting towards more accessible and user-friendly biobanking solutions, emphasizing transparency and ethical sample handling. Competitive dynamics are intensifying, with established players investing heavily in R&D and emerging companies focusing on niche applications and specialized sample types. The biobanking market penetration is steadily increasing across developed and developing economies, driven by government initiatives supporting life sciences research and the establishment of national biobanking networks. The increasing integration of stem cell biobanking and cord banking services further propels market growth, catering to the rising demand for regenerative therapies.
Leading Markets & Segments in Biobanking Industry
North America currently dominates the biobanking industry, driven by substantial government funding for research, a well-established pharmaceutical sector, and a high adoption rate of advanced technologies. The United States, in particular, represents a significant market share. Within the Equipment segment, Cryogenic Storage Systems—encompassing refrigerators, ice machines, and freezers—are the leading sub-segment, crucial for preserving sample integrity at extremely low temperatures. The Sample Type segment is dominated by Human Tissue Biobanking and Stem Cell Biobanking, directly linked to advancements in regenerative medicine and personalized treatments. The Drug Discovery application segment is a primary growth engine, as biobanks provide essential resources for identifying drug targets and testing novel compounds.
- Dominant Region: North America
- Leading Country: United States
- Key Equipment Segment: Cryogenic Storage Systems (Refrigerators, Ice Machines, Freezers)
- Dominant Sample Type: Human Tissue Biobanking, Stem Cell Biobanking
- Leading Application: Drug Discovery
- Key Drivers: Government funding, pharmaceutical R&D, technological adoption, growing prevalence of chronic diseases.
Biobanking Industry Product Developments
Recent product developments in the biobanking industry are focused on enhancing sample traceability, security, and data integration. Innovations in automated sample tracking systems, advanced liquid nitrogen freezers with precise temperature control, and secure cloud-based data management platforms are gaining traction. Companies are also developing specialized solutions for niche sample types, such as DNA/RNA Biobanking, to support complex genomic research. These advancements provide competitive advantages by enabling more efficient research workflows and ensuring the long-term viability of precious biological samples for applications ranging from regenerative medicine to disease research.
Key Drivers of Biobanking Industry Growth
The biobanking industry's growth is propelled by several interconnected factors. Technological advancements, including high-throughput screening and advanced genomic analysis tools, are increasing the demand for well-characterized biological samples. Economic factors such as rising healthcare expenditure and increased R&D investments by pharmaceutical and biotechnology companies are also significant drivers. Furthermore, favorable government policies and initiatives aimed at promoting life sciences research and the development of precision medicine create a conducive environment for biobanking expansion. The increasing global focus on regenerative medicine and the development of personalized therapies directly fuels the need for high-quality biological samples.
Challenges in the Biobanking Industry Market
Despite its growth potential, the biobanking industry faces several challenges. Stringent and evolving regulatory frameworks surrounding data privacy and sample handling can create compliance hurdles and increase operational costs. The complexity of managing vast biological sample collections and associated data presents significant logistical and technical challenges. Supply chain disruptions, particularly for specialized equipment and reagents, can impact operational efficiency. Intense competition among biobanking service providers and the high initial investment required for establishing and maintaining state-of-the-art facilities also pose significant barriers.
Emerging Opportunities in Biobanking Industry
The biobanking industry is ripe with emerging opportunities driven by several catalysts. Technological breakthroughs in areas like CRISPR gene editing and advanced cell culture techniques are creating new demands for specialized biobanking services. Strategic partnerships between academic institutions, research organizations, and commercial biobanks are fostering collaboration and knowledge sharing. Market expansion into emerging economies, where healthcare infrastructure and research capabilities are rapidly developing, presents significant long-term growth potential. The increasing focus on rare disease research and the development of personalized cancer therapies also opens new avenues for specialized biobanking solutions.
Leading Players in the Biobanking Industry Sector
- Becton Dickinson and Company
- Biovault Family
- BioLifeSolutions Inc
- Precision Cellular Storage Ltd (Virgin Health Bank)
- Tecan Group (Tecan Trading AG)
- STEMCELL Technologies Inc
- Thermo Fisher Scientific Inc
- Merck KGaA (Sigma-Aldrich Inc)
- CENTOGENE NV
- Hamilton Company
- Avantor (VWR International LLC)
- Bio-Techne Corporation (Atlanta Biologicals Inc)
Key Milestones in Biobanking Industry Industry
- March 2023: South Africa launched a central biobank system to coordinate up to a million biological samples collected over the past 200 years and scattered across its universities, research facilities, and national parks, aiming to streamline research and discovery efforts.
- May 2022: BC Platforms (BCP) secured a multi-year contract to work with three Finnish Hospital District-owned Biobanks on improving access to and automated management of phenotypic, genomic, and clinical data, supporting Finland's ambition to be a leader in Real-World Data (RWD) studies and enhancing healthcare system resilience.
Strategic Outlook for Biobanking Industry Market
The strategic outlook for the biobanking industry is highly promising, characterized by sustained growth and innovation. Key accelerators include the expanding applications of biobanking in regenerative medicine, drug discovery, and personalized diagnostics, driven by a deepening understanding of human biology. Strategic opportunities lie in the development of integrated biobanking solutions that combine sample storage, advanced analytics, and robust data management platforms. Furthermore, strategic partnerships and collaborations will be crucial for navigating complex regulatory landscapes and expanding global reach, particularly in underserved markets. The increasing demand for high-quality, well-annotated biological samples will continue to fuel investments in advanced technologies and infrastructure, positioning the biobanking industry as a critical enabler of future healthcare advancements.
Biobanking Industry Segmentation
-
1. Equipment
-
1.1. Cryogenic Storage Systems
- 1.1.1. Refrigerators
- 1.1.2. Ice Machines
- 1.1.3. Freezers
- 1.2. Alarm Monitoring Systems
- 1.3. Other Equipment
-
1.1. Cryogenic Storage Systems
-
2. Sample Type
- 2.1. Human Tissue Biobanking
- 2.2. Stem Cell Biobanking
- 2.3. Cord Banking
- 2.4. DNA/RNA Biobanking
- 2.5. Other Services
-
3. Application
- 3.1. Regenerative Medicine
- 3.2. Drug Discovery
- 3.3. Disease Research
Biobanking Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Biobanking Industry Regional Market Share
Geographic Coverage of Biobanking Industry
Biobanking Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 4.99% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Innovations in Regenerative Medicine; Growing Incidences of Chronic Diseases; Advances in Drug Discovery and Development; R&D Funding and Investments by Government and Non-Governmental Organizations
- 3.3. Market Restrains
- 3.3.1. Regulatory Issues; Cost Constraints
- 3.4. Market Trends
- 3.4.1. The Human Tissue Biobanking Segment is Expected to Hold Significant Market Share During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Biobanking Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Equipment
- 5.1.1. Cryogenic Storage Systems
- 5.1.1.1. Refrigerators
- 5.1.1.2. Ice Machines
- 5.1.1.3. Freezers
- 5.1.2. Alarm Monitoring Systems
- 5.1.3. Other Equipment
- 5.1.1. Cryogenic Storage Systems
- 5.2. Market Analysis, Insights and Forecast - by Sample Type
- 5.2.1. Human Tissue Biobanking
- 5.2.2. Stem Cell Biobanking
- 5.2.3. Cord Banking
- 5.2.4. DNA/RNA Biobanking
- 5.2.5. Other Services
- 5.3. Market Analysis, Insights and Forecast - by Application
- 5.3.1. Regenerative Medicine
- 5.3.2. Drug Discovery
- 5.3.3. Disease Research
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Equipment
- 6. North America Biobanking Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Equipment
- 6.1.1. Cryogenic Storage Systems
- 6.1.1.1. Refrigerators
- 6.1.1.2. Ice Machines
- 6.1.1.3. Freezers
- 6.1.2. Alarm Monitoring Systems
- 6.1.3. Other Equipment
- 6.1.1. Cryogenic Storage Systems
- 6.2. Market Analysis, Insights and Forecast - by Sample Type
- 6.2.1. Human Tissue Biobanking
- 6.2.2. Stem Cell Biobanking
- 6.2.3. Cord Banking
- 6.2.4. DNA/RNA Biobanking
- 6.2.5. Other Services
- 6.3. Market Analysis, Insights and Forecast - by Application
- 6.3.1. Regenerative Medicine
- 6.3.2. Drug Discovery
- 6.3.3. Disease Research
- 6.1. Market Analysis, Insights and Forecast - by Equipment
- 7. Europe Biobanking Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Equipment
- 7.1.1. Cryogenic Storage Systems
- 7.1.1.1. Refrigerators
- 7.1.1.2. Ice Machines
- 7.1.1.3. Freezers
- 7.1.2. Alarm Monitoring Systems
- 7.1.3. Other Equipment
- 7.1.1. Cryogenic Storage Systems
- 7.2. Market Analysis, Insights and Forecast - by Sample Type
- 7.2.1. Human Tissue Biobanking
- 7.2.2. Stem Cell Biobanking
- 7.2.3. Cord Banking
- 7.2.4. DNA/RNA Biobanking
- 7.2.5. Other Services
- 7.3. Market Analysis, Insights and Forecast - by Application
- 7.3.1. Regenerative Medicine
- 7.3.2. Drug Discovery
- 7.3.3. Disease Research
- 7.1. Market Analysis, Insights and Forecast - by Equipment
- 8. Asia Pacific Biobanking Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Equipment
- 8.1.1. Cryogenic Storage Systems
- 8.1.1.1. Refrigerators
- 8.1.1.2. Ice Machines
- 8.1.1.3. Freezers
- 8.1.2. Alarm Monitoring Systems
- 8.1.3. Other Equipment
- 8.1.1. Cryogenic Storage Systems
- 8.2. Market Analysis, Insights and Forecast - by Sample Type
- 8.2.1. Human Tissue Biobanking
- 8.2.2. Stem Cell Biobanking
- 8.2.3. Cord Banking
- 8.2.4. DNA/RNA Biobanking
- 8.2.5. Other Services
- 8.3. Market Analysis, Insights and Forecast - by Application
- 8.3.1. Regenerative Medicine
- 8.3.2. Drug Discovery
- 8.3.3. Disease Research
- 8.1. Market Analysis, Insights and Forecast - by Equipment
- 9. Middle East and Africa Biobanking Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Equipment
- 9.1.1. Cryogenic Storage Systems
- 9.1.1.1. Refrigerators
- 9.1.1.2. Ice Machines
- 9.1.1.3. Freezers
- 9.1.2. Alarm Monitoring Systems
- 9.1.3. Other Equipment
- 9.1.1. Cryogenic Storage Systems
- 9.2. Market Analysis, Insights and Forecast - by Sample Type
- 9.2.1. Human Tissue Biobanking
- 9.2.2. Stem Cell Biobanking
- 9.2.3. Cord Banking
- 9.2.4. DNA/RNA Biobanking
- 9.2.5. Other Services
- 9.3. Market Analysis, Insights and Forecast - by Application
- 9.3.1. Regenerative Medicine
- 9.3.2. Drug Discovery
- 9.3.3. Disease Research
- 9.1. Market Analysis, Insights and Forecast - by Equipment
- 10. South America Biobanking Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Equipment
- 10.1.1. Cryogenic Storage Systems
- 10.1.1.1. Refrigerators
- 10.1.1.2. Ice Machines
- 10.1.1.3. Freezers
- 10.1.2. Alarm Monitoring Systems
- 10.1.3. Other Equipment
- 10.1.1. Cryogenic Storage Systems
- 10.2. Market Analysis, Insights and Forecast - by Sample Type
- 10.2.1. Human Tissue Biobanking
- 10.2.2. Stem Cell Biobanking
- 10.2.3. Cord Banking
- 10.2.4. DNA/RNA Biobanking
- 10.2.5. Other Services
- 10.3. Market Analysis, Insights and Forecast - by Application
- 10.3.1. Regenerative Medicine
- 10.3.2. Drug Discovery
- 10.3.3. Disease Research
- 10.1. Market Analysis, Insights and Forecast - by Equipment
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Becton Dickinson and Company
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Biovault Family
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 BioLifeSolutions Inc
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Precision Cellular Storage Ltd (Virgin Health Bank)*List Not Exhaustive
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Tecan Group (Tecan Trading AG)
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 STEMCELL Technologies Inc
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Thermo Fisher Scientific Inc
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Merck KGaA (Sigma-Aldrich Inc )
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 CENTOGENE NV
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Hamilton Company
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Avantor (VWR International LLC)
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Bio-Techne Corporation (Atlanta Biologicals Inc )
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: Global Biobanking Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: North America Biobanking Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 3: North America Biobanking Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 4: North America Biobanking Industry Revenue (Million), by Sample Type 2025 & 2033
- Figure 5: North America Biobanking Industry Revenue Share (%), by Sample Type 2025 & 2033
- Figure 6: North America Biobanking Industry Revenue (Million), by Application 2025 & 2033
- Figure 7: North America Biobanking Industry Revenue Share (%), by Application 2025 & 2033
- Figure 8: North America Biobanking Industry Revenue (Million), by Country 2025 & 2033
- Figure 9: North America Biobanking Industry Revenue Share (%), by Country 2025 & 2033
- Figure 10: Europe Biobanking Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 11: Europe Biobanking Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 12: Europe Biobanking Industry Revenue (Million), by Sample Type 2025 & 2033
- Figure 13: Europe Biobanking Industry Revenue Share (%), by Sample Type 2025 & 2033
- Figure 14: Europe Biobanking Industry Revenue (Million), by Application 2025 & 2033
- Figure 15: Europe Biobanking Industry Revenue Share (%), by Application 2025 & 2033
- Figure 16: Europe Biobanking Industry Revenue (Million), by Country 2025 & 2033
- Figure 17: Europe Biobanking Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: Asia Pacific Biobanking Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 19: Asia Pacific Biobanking Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 20: Asia Pacific Biobanking Industry Revenue (Million), by Sample Type 2025 & 2033
- Figure 21: Asia Pacific Biobanking Industry Revenue Share (%), by Sample Type 2025 & 2033
- Figure 22: Asia Pacific Biobanking Industry Revenue (Million), by Application 2025 & 2033
- Figure 23: Asia Pacific Biobanking Industry Revenue Share (%), by Application 2025 & 2033
- Figure 24: Asia Pacific Biobanking Industry Revenue (Million), by Country 2025 & 2033
- Figure 25: Asia Pacific Biobanking Industry Revenue Share (%), by Country 2025 & 2033
- Figure 26: Middle East and Africa Biobanking Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 27: Middle East and Africa Biobanking Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 28: Middle East and Africa Biobanking Industry Revenue (Million), by Sample Type 2025 & 2033
- Figure 29: Middle East and Africa Biobanking Industry Revenue Share (%), by Sample Type 2025 & 2033
- Figure 30: Middle East and Africa Biobanking Industry Revenue (Million), by Application 2025 & 2033
- Figure 31: Middle East and Africa Biobanking Industry Revenue Share (%), by Application 2025 & 2033
- Figure 32: Middle East and Africa Biobanking Industry Revenue (Million), by Country 2025 & 2033
- Figure 33: Middle East and Africa Biobanking Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: South America Biobanking Industry Revenue (Million), by Equipment 2025 & 2033
- Figure 35: South America Biobanking Industry Revenue Share (%), by Equipment 2025 & 2033
- Figure 36: South America Biobanking Industry Revenue (Million), by Sample Type 2025 & 2033
- Figure 37: South America Biobanking Industry Revenue Share (%), by Sample Type 2025 & 2033
- Figure 38: South America Biobanking Industry Revenue (Million), by Application 2025 & 2033
- Figure 39: South America Biobanking Industry Revenue Share (%), by Application 2025 & 2033
- Figure 40: South America Biobanking Industry Revenue (Million), by Country 2025 & 2033
- Figure 41: South America Biobanking Industry Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Biobanking Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 2: Global Biobanking Industry Revenue Million Forecast, by Sample Type 2020 & 2033
- Table 3: Global Biobanking Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 4: Global Biobanking Industry Revenue Million Forecast, by Region 2020 & 2033
- Table 5: Global Biobanking Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 6: Global Biobanking Industry Revenue Million Forecast, by Sample Type 2020 & 2033
- Table 7: Global Biobanking Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 8: Global Biobanking Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 9: United States Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 10: Canada Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 11: Mexico Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 12: Global Biobanking Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 13: Global Biobanking Industry Revenue Million Forecast, by Sample Type 2020 & 2033
- Table 14: Global Biobanking Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 15: Global Biobanking Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Germany Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 17: United Kingdom Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: France Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 19: Italy Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 20: Spain Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 21: Rest of Europe Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 22: Global Biobanking Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 23: Global Biobanking Industry Revenue Million Forecast, by Sample Type 2020 & 2033
- Table 24: Global Biobanking Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 25: Global Biobanking Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 26: China Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 27: Japan Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 28: India Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 29: Australia Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 30: South Korea Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 31: Rest of Asia Pacific Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Global Biobanking Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 33: Global Biobanking Industry Revenue Million Forecast, by Sample Type 2020 & 2033
- Table 34: Global Biobanking Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 35: Global Biobanking Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 36: GCC Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 37: South Africa Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: Rest of Middle East and Africa Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 39: Global Biobanking Industry Revenue Million Forecast, by Equipment 2020 & 2033
- Table 40: Global Biobanking Industry Revenue Million Forecast, by Sample Type 2020 & 2033
- Table 41: Global Biobanking Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 42: Global Biobanking Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 43: Brazil Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 44: Argentina Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 45: Rest of South America Biobanking Industry Revenue (Million) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Biobanking Industry?
The projected CAGR is approximately 4.99%.
2. Which companies are prominent players in the Biobanking Industry?
Key companies in the market include Becton Dickinson and Company, Biovault Family, BioLifeSolutions Inc, Precision Cellular Storage Ltd (Virgin Health Bank)*List Not Exhaustive, Tecan Group (Tecan Trading AG), STEMCELL Technologies Inc, Thermo Fisher Scientific Inc, Merck KGaA (Sigma-Aldrich Inc ), CENTOGENE NV, Hamilton Company, Avantor (VWR International LLC), Bio-Techne Corporation (Atlanta Biologicals Inc ).
3. What are the main segments of the Biobanking Industry?
The market segments include Equipment, Sample Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 52.72 Million as of 2022.
5. What are some drivers contributing to market growth?
Innovations in Regenerative Medicine; Growing Incidences of Chronic Diseases; Advances in Drug Discovery and Development; R&D Funding and Investments by Government and Non-Governmental Organizations.
6. What are the notable trends driving market growth?
The Human Tissue Biobanking Segment is Expected to Hold Significant Market Share During the Forecast Period.
7. Are there any restraints impacting market growth?
Regulatory Issues; Cost Constraints.
8. Can you provide examples of recent developments in the market?
March 2023: South Africa launched a central biobank system to coordinate up to a million biological samples collected over the past 200 years and scattered across its universities, research facilities, and national parks.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Biobanking Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Biobanking Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Biobanking Industry?
To stay informed about further developments, trends, and reports in the Biobanking Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence